Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical characteristics and genetic analysis of a Chinese pedigree of type 2 diabetes complicated with interstitial lung disease. | Front Endocrinol (Lausanne) | 2022 | 36733806 | PubTator, text mining | PubMed |
| MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated. | Front Cell Dev Biol | 2022 | 36726591 | PubTator, text mining | PubMed |
| Development and validation of a GRGPI model for predicting the prognostic and treatment outcomes in head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36713509 | PubTator, text mining | PubMed |
| Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy. | Front Immunol | 2022 | 36703982 | PubTator, text mining | PubMed |
| Contribution of natural killer cells in innate immunity against colorectal cancer. | Front Oncol | 2022 | 36686835 | PubTator, text mining | PubMed |
| Immune-related potential biomarkers and therapeutic targets in coronary artery disease. | Front Cardiovasc Med | 2022 | 36684561 | PubTator, text mining | PubMed |
| Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma. | J Pers Med | 2022 | 36675674 | PubTator, text mining | PubMed |
| Immunogenetic Predisposition to SARS-CoV-2 Infection. | Biology (Basel) | 2022 | 36671730 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T-cell therapy for multiple myeloma. | Front Immunol | 2022 | 36618390 | PubTator, text mining | PubMed |
| Interleukin-15 and chemokine ligand 19 enhance cytotoxic effects of chimeric antigen receptor T cells using zebrafish xenograft model of gastric cancer. | Front Immunol | 2022 | 36618357 | PubTator, text mining | PubMed |
| The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity. | Int J Mol Sci | 2022 | 36613838 | PubTator, text mining | PubMed |
| Natural Killer Cell Receptors and Endometriosis: A Systematic Review. | Int J Mol Sci | 2022 | 36613776 | PubTator, text mining | PubMed |
| Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia. | Front Immunol | 2022 | 36605213 | PubTator, text mining | PubMed |
| A survival prediction model and nomogram based on immune-related gene expression in chronic lymphocytic leukemia cells. | Front Med (Lausanne) | 2022 | 36600891 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma. | Front Oncol | 2022 | 36591519 | PubTator, text mining | PubMed |
| Altered serum human cytomegalovirus microRNA levels are common and closely associated with the inflammatory status in patients with fever. | Front Immunol | 2022 | 36591247 | PubTator, text mining | PubMed |
| IL-15 induced bystander activation of CD8+ T cells may mediate endothelium injury through NKG2D in Hantaan virus infection. | Front Cell Infect Microbiol | 2022 | 36590594 | PubTator, text mining | PubMed |
| Editorial: The interaction of NKG2D and its ligands in health and diseases. | Front Immunol | 2022 | 36569955 | PubTator, text mining | PubMed |
| Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes. | Front Oncol | 2022 | 36568252 | PubTator, text mining | PubMed |
| Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity. | NPJ Genom Med | 2022 | 36564402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=27